Recall Record

Montreal, N/A, Canada

AMD Medicom Inc. recalls

3 recalls recorded since 2018, most recently on 8 May 2026. 2 are listed as ongoing. Status and classification are as published by the FDA.

Recalls3
Ongoing (FDA)2
Terminated or completed1
Class I (FDA)0

Ongoing Class II Medical devices

Recall started
8 May 2026
Reason
Neurological sponges used to moisten or absorb biological fluid during neurological surgery and may also be used to protect the brain during incision, may not consistently meet endotoxin specification for devices that contact the cerebrospinal fluid. Elevated endotoxin levels may lead to neurovascular adverse events, febrile response, and/or local transient inflammation, hypotension, or nausea.
Distribution
US: MT, NC, VA, CA, TX, OH, TN, IL, RI
Initiated
Voluntary: Firm initiated
Recall numbers
Z-2458-2026, Z-2459-2026

Ongoing Class II Medical devices

Recall started
21 December 2023
Reason
Level 3 masks were produced on alternate non-validated production equipment that were not included as part of the initial qualification of the products.
Distribution
US Nationwide distribution in the states of FL, IA, IN, PA, NV, TX.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-1148-2024, Z-1146-2024, Z-1147-2024

Terminated Class II Medical devices

Recall started
11 October 2019
Terminated
14 September 2021
Reason
Due to an error on the packaging line, some level 2 masks may have been packed in some level 3 mask boxes. The two masks are visually indistinguishable, causing the risk of using a mask with a lower protection level than intended.
Distribution
The products were distributed tot he following US states: CA, FL, IA, IN, MD, MI, NV, NY, PA, SC, TN, TX, and WA. The products were distributed to the following foreign countries: Canada.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-0494-2020, Z-0495-2020

A terminated FDA recall means the FDA has determined that all reasonable efforts to remove or correct the product have been made. What statuses mean.